News Releases

Cabaletta - Investor Relations

Staying on the pulse of the latest developments

Follow the news and developments of our breakthrough discovery and development of cellular therapies for immune-mediated diseases.

The press releases contained in this section are provided for historical purposes only. The information contained in each press release is accurate only as of the date each press release was originally issued. Cabaletta disavows any obligation to update the information contained in such press releases after the date of their issuance. 

Cabaletta - Investor Tools